Full text is available at the source.
Abstract
Glucagon-like peptide-1 (GLP-1) analogues may offer a new treatment option for high output stoma complications.
- High output stoma is a significant complication following intestinal resection in patients with an enterostomy or enterocutaneous fistula.
- Conventional treatments for high output stoma are limited and often ineffective.
- GLP-1 analogues are being explored for their potential to influence gastrointestinal motility.
- A defined stepwise treatment approach for managing high output stoma has not yet been established.
Simplified